Liu L - Search Results

1

A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer.

Cao Y, Tan A, Gao F, Liu L, Liao C, Mo Z. Cao Y, et al. Among authors: liu l. Int J Colorectal Dis. 2009 Jun;24(6):677-85. doi: 10.1007/s00384-009-0655-9. Epub 2009 Jan 30. Int J Colorectal Dis. 2009. PMID: 19184059

2

Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials.

Liu L, Cao Y, Tan A, Liao C, Gao F. Liu L, et al. Cancer Chemother Pharmacol. 2010 Apr;65(5):849-61. doi: 10.1007/s00280-009-1090-x. Epub 2009 Aug 13. Cancer Chemother Pharmacol. 2010. PMID: 19680654

3

Meta-analysis of incidence and risk of hypokalemia with cetuximab-based therapy for advanced cancer.

Cao Y, Liu L, Liao C, Tan A, Gao F. Cao Y, et al. Among authors: liu l. Cancer Chemother Pharmacol. 2010 May;66(1):37-42. doi: 10.1007/s00280-009-1131-5. Epub 2009 Sep 17. Cancer Chemother Pharmacol. 2010. PMID: 19760217

4

Meta-analysis of incidence and risk of hypomagnesemia with cetuximab for advanced cancer.

Cao Y, Liao C, Tan A, Liu L, Gao F. Cao Y, et al. Among authors: liu l. Chemotherapy. 2010;56(6):459-65. doi: 10.1159/000321011. Epub 2010 Nov 18. Chemotherapy. 2010. PMID: 21088398

5

Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer.

Cao Y, Wu L, Tan A, Liu L, Liao C, Gao F. Cao Y, et al. Among authors: liu l. Pancreas. 2010 Mar;39(2):253-5. doi: 10.1097/MPA.0b013e3181bdc6b8. Pancreas. 2010. PMID: 20182311 No abstract available.

6

IMRT combined with S-1 concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a prospective phase II study.

Lv T, Wang Y, Ou D, Liu P, Qin S, Liu L, Lou P, Wang X. Lv T, et al. Among authors: liu l, liu p. Invest New Drugs. 2019 Apr;37(2):352-359. doi: 10.1007/s10637-018-00720-0. Epub 2019 Jan 8. Invest New Drugs. 2019. PMID: 30617703 Clinical Trial.

7

Safety and clinical efficacy of neoadjuvant chemoradiation therapy with immunotherapy for organ preservation in ultra-low rectal cancer: preliminary results of the CHOICE-I trial: a prospective cohort study.

Zhou L, Yu G, Shen Y, Wen R, Ding H, Zhou J, Zhu X, Hong Y, Gong H, Liu L, Wang H, Zhang H, Bai C, Hao L, Zhang W. Zhou L, et al. Among authors: liu l. Int J Surg. 2025 Jan 7. doi: 10.1097/JS9.0000000000002225. Online ahead of print. Int J Surg. 2025. PMID: 39764608

8

Extremely low lattice thermal conductivity in light-element solid materials.

Ma N, Liu L, Wu R, Xu J, Yin W, Li K, Bai W, Yang J, Xiao C, Xie Y. Ma N, et al. Among authors: liu l. Natl Sci Rev. 2024 Sep 28;12(1):nwae345. doi: 10.1093/nsr/nwae345. eCollection 2025 Jan. Natl Sci Rev. 2024. PMID: 39764510 Free PMC article.

9

The value of radiomics-based hyperdense middle cerebral artery sign in predicting hemorrhagic transformation in acute ischemic stroke patients undergoing endovascular treatment.

Gong C, Liu Y, Ma W, Jing Y, Liu L, Huang Y, Yang J, Feng C, Fang Y, Fang W. Gong C, et al. Among authors: liu l. Front Neurol. 2024 Dec 23;15:1492089. doi: 10.3389/fneur.2024.1492089. eCollection 2024. Front Neurol. 2024. PMID: 39764291 Free PMC article.

10

Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia.

Akif A, Nguyen TTM, Liu L, Xu X, Kulkarni A, Jiang J, Zhang Y, Hao J. Akif A, et al. Among authors: liu l. Res Sq [Preprint]. 2024 Dec 20:rs.3.rs-5611378. doi: 10.21203/rs.3.rs-5611378/v1. Res Sq. 2024. PMID: 39764140 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,764 results

Search Page

Filters